We undertook a study to assess the feasibility of using a rat model of Acanthamoeba keratitis described by Larkin and Eastl to determine the efficacy of different medical treatments in vivo.
Briefly, the central corneal stroma of 60 male rats was inoculated with an axenic cyst suspension of Acanthamoeba polyphagia, and the resultant kerati tis graded after 3 days by slit lamp examination ( Table I) . The animals were then treated in a masked fashion with either propamidine isethionate 1%, polyhexamethylene biguanide 0.02 % (PHMB) or vehicle instilled every 6 hours for 14 days. Further clinical grading of keratitis was done on days 5, 7, 10, 13 and 16, after which the animals were killed and the corneas homogenised and cultured.
There was no significant difference in the mean grade of keratitis between the three groups prior to commencing, during or at the completion of treat ment, using Fisher's test of variance (Table II) . There was also no significant difference in the number of CUlture-positive corneas between the treatment groups using the chi-squared test with Yates' correction ( Table III) 
